At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine prevention.

Plans to locate a playground on the Fairgreen in Longwood village have been met by opposition from several residents living ...

Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today announced that data from several new ...

Hawaii Sen. Brian Schatz claimed in January ahead of RFK Jr.'s confirmation hearing, "In 2019, [RFK Jr.] flew to Samoa to discourage people from taking the measles vaccine, deepening hesitancy that ...

Bryan Johnson, a biohacking enthusiast, has spent millions trying to slow aging. Instead, his use of the drug rapamycin may ...

On September 16, 2020, 18-year-old Becca Schmill died from drug poisoning after ingesting fentanyl-laced cocaine she bought on Facebook.

MALAPPURAM: ‘Say no to drugs’ was a refrain at functions organised by Muslim religious organisations to mark Eid-ul-Fitr ...

VY1706 is in Investigational New Drug (IND)-enabling studies with an IND filing expected in 2026. VY7523 anti-tau antibody ... imaging data in the second half of 2026. The posters can be accessed on ...

Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety ...

demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327, exhibits anti-tumor activity and a ...